(Q34062253)

30 July 2017

1 reference

title

Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults (English)

1 reference

30 July 2017

Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Sarcoma Meta-analysis Collaboration (SMAC) (English)

0 references

1 reference

1 reference

1 reference

Sarcoma Meta-analysis Collaboration (SMAC)

series ordinal

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

30 July 2017

2000

0 references

published in

1 reference

30 July 2017

4

1 reference

30 July 2017

2

0 references

page(s)

CD001419

1 reference

Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas

30 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

The treatment of soft tissue sarcomas with focus on chemotherapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

Adriamycin. A new anticancer drug with significant clinical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

Tables of the number of patients required in clinical trials using the logrank test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

A randomized prospective trial using postoperative adjuvant chemotherapy (adriamycin) in high-grade extremity soft-tissue sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

Adriamycin: A new effective agent in the therapy of disseminated sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001419

10.1002/14651858.CD001419

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference